🇺🇸 FDA
Pipeline program

IOBENGUANE (123I) , 68Ga-SSO120

PS21GAP

Phase 2 small_molecule active

Quick answer

IOBENGUANE (123I) , 68Ga-SSO120 for neuroblastoma is a Phase 2 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
AXIM BIOTECHNOLOGIES, INC.
Indication
neuroblastoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials